A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers ...
Morning Overview on MSN
The two drugs that just cleared Alzheimer’s plaques in mice already sit in pharmacies as cancer treatments — a shortcut that could reach patients years sooner
In 2012, neuroscientist Gary Landreth and his team at Case Western Reserve University published a finding in Science that ...
Lormalzi, also known as Donanemab, is a next-generation Alzheimer’s therapy designed for people with mild cognitive ...
The therapy has already been approved in the UAE, US and Europe, but access and monitoring remain major challenges.
Morning Overview on MSN
Scientists just flagged an enzyme called IDOL as a powerful new Alzheimer’s target — one that controls how the brain handles toxic cholesterol
Nearly seven million Americans are living with Alzheimer’s disease, and the handful of treatments approved in recent years ...
New research reveals a statistical technique used in Alzheimer's drug trials inflates clinical efficacy claims by 29x.
A new nanotechnology treatment reversed Alzheimer’s symptoms in mice by restoring the brain’s natural cleanup system. The specially engineered nanoparticles helped clear toxic amyloid proteins from ...
MedPage Today on MSN
Study Questions Methods Used in Alzheimer's Drug Analysis
Quantile aggregation may lead to overstated claims about amyloid-cognition relationships ...
For the first time, therapeutically effective medications are now available for Alzheimer's disease. Effective symptomatic ...
Poorer subjective sleep quality was linked to worse visual memory and greater limbic tau burden in older women with higher ...
Alzheimer's is the most common form of dementia, accounting for 60-70% of cases, and is growing at a scale that is still not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results